-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904. Outcomes Research: Hemoglobinopathies: Poster II

Symposia: Outcomes Research: Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Uday Yanamandra, MD, DM1,2, Harikrishnan Premdeep, MD3*, Akash Dixit4*, J Muthukrishnan, MD5*, Narendra Kotwal6*, Velu Nair, MBBS, MD7,8 and Lakshmanan Krishnamurti, MD9

1Internal Medicine and Hematology, Armed Forces Medical College, Pune, IND
2Internal Medicine and Hematology, Armed Forces Medical College, Pune, India
3INTERNAL MEDICINE, ARMED FORCES MEDICAL COLLEGE, PUNE, India
4ARMED FORCES MEDICAL COLLEGE, PUNE, India
5Internal Medicine, Armed Forces Medical College, Pune, India
6Armed Forces Medical College, Pune, India
7Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, India
8Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, IND
9Section of Pediatric Hematology/Oncology/BMT, Yale School of Medicine, Atlanta, GA

Natasha Archer, MD, MPH1, Alexandra Power-Hays, MD2, Erin Auriel Hendry, BA3*, Marin Valentino3*, Matthew Hall4*, Kathryn Kyler5*, James Antoon6*, Sonya Tang Girdwood7*, Jennifer L. Goldman8*, Armand Morel9*, Timothy Savage10*, Lucas Orth11* and Ashley M Jenkins, MD, MSc12

1Dana–Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
2Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3University of Rochester Medical Center, Rochester, NY
4Children's Hospital Association, Leawood, KS
5Children's Mercy Kansas City, Kansas City, KS
6Vanderbuilt University Medical Center, Nashiville, TN
7Department of Pediatrics, University of Cincinnati, Cincinnati
8Divisions Pediatric Infectious Diseases and Clinical Pharmacology, Children's Mercy Kansas City, Kansas City
9Children's Mercy Kansas City, Kansas City
10Brigham and Women’s Hospital, Boston
11University of Colorado Skaggs School of Pharmacy, Aurora
12Departments of Medicine and Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY

Joshua Rivenbark, MD, PhD1 and Jane A. Little, MD2

1Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill
2University of North Carolina, Chapel Hill, NC

Catie Clyde1*, Srila Gopal, MD2,3 and Jhaqueline Valle, MPH1*

1Tracking California, Public Health Institute, Oakland, CA
2University of California San Diego Health, San Diego, CA
3Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA

Gerard Hills, MD1, Harlan Nelson, MS2*, Shaun Grannis, MD, MS3* and Michael R. DeBaun, MD, MPH4

1Department of Pediatrics / Division Pediatric Hematology/Oncology, Indiana University School of Medicine / Regenstrief Institute, Indianapolis, IN
2Indiana University Health, Indianapolis, IN
3Center of Biomedical Informatics, Regenstrief Institute, Indianapolis, IN
4Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN

Seema Bhatwadekar, MD, MBBS1, Shubhangi Deshpande, MD MBBS2*, Ujjwala Lakhmapurkar3*, Smruti Kanade4*, Asmita Bhave4* and Shrinivas Bhatwadekar3*

1Haemato Oncology Care Centre, Vadodara, Gujarat, India
2Department of Medicine, GMERS Medical College and Hospital Gotri Vadodara, Vadodara, India
3Haemato Oncology Care Centre, Vadodara, India
4Baroda Medical College and SSG Hospital, Vadodara, India

Alejandro Julian Vera1*, Porooshat Dadgostar1*, Naomi Booker2*, Regina Dennis1*, Francis W Coyne, MD1, Lalita Movva, MD1*, Kevin Fiscella, MD, MPH1*, Sharee Turpin3*, Reza Yousefi-Nooraie, PhD, MSc1* and Ashley M Jenkins, MD, MSc4

1University of Rochester Medical Center, Rochester, NY
2University of South Carolina, Columbia, SC
3ROC City Sicklers, Rochester, NY
4Departments of Medicine and Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY

Tori Langmuir1*, Guolian Kang, PhD2, Doralina Anghelescu, MD2*, Jason Hodges, PhD2, Jerlym Porter, PhD, MPH2, Keesha Roach, PhD3, Jane S Hankins, MD, MS2, Parul Rai, MD, MBBS2, Clifford M. Takemoto, MD2 and Nicole M. Alberts, PhD1*

1Concordia University, Montreal, QC, Canada
2St. Jude Children's Research Hospital, Memphis, TN
3University of Tennessee Health Science Center, Marion, AR

Emily Franco, BA1,2, Lisbel Gonzalez, BA1*, Allison McGirr-Crowley, LCSW1*, Christina D'Angelo, PhD1*, Ernestine Jennings, PhD1*, David Gardner, MSN, NP3*, Manpreet Kochhar, MD, MS4*, Lydia Musula, PA-C1*, Kristine Karkoska, MD, MS5 and Patrick T. McGann, MD, PhD6

1Lifespan Comprehensive Sickle Cell Center, Providence, RI
2The Warren Alpert Medical School of Brown University, Davie, FL
3Lifespan Cancer Institute, Providence, RI
4The Warren Alpert Medical School at Brown University, Hasbro Children's Hospital, Providence, RI
5University of Cincinnati College of Medicine, Cincinnati, OH
6Brown University Health Sickle Cell Center, Providence, RI

Terri Victoria Newman, MS, PharmD1*, Jingye Yang, MS1*, Aaron Haubner, PhD2*, Melissa Anderson, MD, PharmD2*, Darrell J Triulzi, MD3* and Enrico M Novelli, MD, MS4,5

1University of Pittsburgh School of Pharmacy, Pittsburgh, PA
2Terumo Blood and Cell Technologies, lakewood, CO
3University of Pittsburgh, Pittsburgh, PA
4Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA
5Vascular Medicine Institute, University of Pittsburgh School of Medicine, pittsbirgj, PA

Katherine Kosa, MS1*, Alejandro Vanegas, MS1*, Carmine Colavecchia, PhD, PharmD2*, Josh Coulter, MA2*, Stephanie A Christopher, MA2*, Ross M. Fasano, MD3*, Stella T. Chou, MD4, Richard A. Drachtman, MD5, David M. Purdie, PhD2, Christine L. Baker, JD, MPH, MBA2* and Emily Riehm Meier, MD, MSHS2

1RTI Health Solutions, Research Triangle Park, NC
2Pfizer Inc, New York, NY
3Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
4Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA
5Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

Lucas Bibiano Oliveira Souza1*, Thaís Olalla Bonon Assis1*, Rogerio Olalla Torres Seber2*, Adriana da Silva Santos Duarte, PhD3*, Audrey Bastos4*, Bruno D Benites, MD, PhD2*, Fernando Ferreira Costa, MD, PhD5 and Sara Teresinha Olalla Saad, MD PhD1

1Hemocentro-Unicamp, Campinas, Sao Paulo, Brazil
2Hemocentro-Unicamp, Campinas, Brazil
3Hematology and Transfusion Medicine Center - University of Campinas/Hemocentro-UNICAMP, Campinas, São Paulo, Brazil
4Hematology and Transfusion Medicine Center, State University of Campinas – UNICAMP, Campinas, Brazil
5Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil

Kemar V. Prussien, PhD1, Lori E. Crosby, PsyD2,3, Margaret Mary Burke, MS4*, Nikhil D. Grobes5*, Madison N. Smith6*, Rosalind J. Wright, MD, MPH7*, Alexis Thompson, MD, MPH1,8 and Lisa A. Schwartz, PhD1,4*

1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH
3Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
5School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA
6Ursinus College, Collegeville, PA
7Icahn School of Medicine at Mount Sinai, New York, NY
8Division of Hematology, Children’s Hospital of Philadelphia, Phildelphia, PA

*signifies non-member of ASH